RT Elements (4.6)
Brainlab SE · Decision date Oct 5, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for RT Elements (4.6), a Brainlab SE radiation therapy treatment planning software submission, on October 5, 2026, under 21 CFR 892.5050 with product codes MUJ and QIH. The public database lists the application as received May 19, 2026, while the FDA letter and 510(k) summary are dated September 10, 2026; the record does not reconcile that difference. SESE is a 510(k) clearance, not premarket approval.
The stated indication covers stereotactic, conformal, computer-planned, linac-based radiation treatment planning for cranial, head and neck and extracranial lesions, in adults only. The summary names RT Elements (4.5), K250440, as predicate and lists modules including Multiple Brain Mets SRS, Cranial SRS, Spine SRS, Cranial SRS w/ Cones, RT Contouring, RT QA, Dose Review and Brain Mets Retreatment Review. The record does not identify which specific changes distinguish 4.6 from 4.5, and no clinical performance data are summarized here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 5, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261655
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Brainlab SE
- Product code
- MUJ
- Decision code
- SESE
- Decision date
- Oct 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Planning, Radiation Therapy Treatment.
- Applicant
- Brainlab SE
- Product code
- MUJ
- FDA device class
- 2
FDA decision timeline
K261655 received
Application receipt date recorded by FDA.
K261655 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Brainlab SE
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Munich
Sources and methodology
- Original FDA record: K261655
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records